ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 3 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $38 | -99.9% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $38,000 | 0.0% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $38,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q1 2022 | $38,000 | – | 6,000 | – | 0.00% | – |
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | -100.0% | 0.00% | – |
| Q4 2020 | $0 | – | 21 | -38.2% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 34 | -99.4% | 0.00% | -100.0% |
| Q1 2019 | $31,000 | +63.2% | 6,000 | 0.0% | 0.00% | +300.0% |
| Q4 2018 | $19,000 | -47.2% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $36,000 | +12.5% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $32,000 | +52.4% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $21,000 | 0.0% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $21,000 | -4.5% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $22,000 | +46.7% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $15,000 | -6.2% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $16,000 | -5.9% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $17,000 | -32.0% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $25,000 | +31.6% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $19,000 | -38.7% | 6,000 | 0.0% | 0.00% | -75.0% |
| Q1 2016 | $31,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 919,000 | $4,816,000 | 2.29% |
| RTW INVESTMENTS, LP | 6,256,840 | $32,786,000 | 2.24% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $2,515,000 | 1.08% |
| Bpifrance SA | 828,262 | $4,340,000 | 0.49% |
| WS MANAGEMENT LLLP | 888,722 | $4,657,000 | 0.28% |
| Eventide Asset Management | 1,146,580 | $6,008,000 | 0.21% |
| 683 Capital Management, LLC | 362,386 | $1,899,000 | 0.17% |
| Orbimed Advisors | 1,243,200 | $6,514,000 | 0.10% |
| Sofinnova Investments, Inc. | 159,237 | $835,000 | 0.08% |
| Rhenman & Partners Asset Management AB | 119,673 | $627,000 | 0.07% |